Kevin Krenitsky, President, Enzo Clinical Labs at ENZO BIOCHEM INC (ENZ), bought 6,600 shares at $7.70 ($51K) on 2009-10-15, disclosed to the SEC on 2009-10-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| OPGN,OPGNW | BUY | 2015-05-12 | $50K | — | Filing → |
| FMI | SELL | 2014-10-03 | $1K | — |
| Filing → |
| FMI | SELL | 2014-07-02 | $2K | — | Filing → |